[METTL3媒介によるm6Aメチル化改変による肺腺がんの侵入と転移の調節におけるpiR-hsa-26925のメカニズム]
1Department of Respiratory and Critical Care Medicine, Qilu Hospital of Shandong University, Ji'nan 250012, China.
Zhonghua yi xue za zhi
|September 4, 2025
まとめ
PIWIと相互作用するRNA piR- hsa- 26925は,METTL3と相互作用し,EPHB2のm6Aメチル化を変化させ,細胞侵入を促進する.
科学分野:
- 分子生物学
- 腫瘍学
- エピジェネティクス
背景:
- 肺腺がんは,がんによる死亡の主な原因です.
- 感染や転移を促す 分子メカニズムを理解することは 効果的な治療法の開発に不可欠です
- PIWI相互作用RNA (piRNAs) は,肺腺がんを含む様々な癌の重要なレギュレータとして出現しています.
研究 の 目的:
- 肺腺癌の進行における piR- hsa-26925 の役割を明らかにする.
- メチルトランスフェラーゼ型3 (METTL3) とN6-メチラデノシン (m6A) の改変を含む根本的なメカニズムを調査する.
- この経路で制御される下流の標的を特定する.
主な方法:
- 定量リアルタイムPCR (qRT-PCR) とウェスタン・ブラッティングで遺伝子とタンパク質の発現を評価する.
- 細胞移動と侵入測定 (スクラッチとトランスウェル)
- RNAプルダウン,RNA免疫降水 (RIP),FISH,およびm6A特有の測定法.
- 標的の識別のためのRNA配列とm6A-RIP配列
主要な成果:
- piR- hsa- 26925は肺腺がん細胞で有意に上昇した.
- piR- hsa-26925のノックダウンは細胞の移動と侵入を減少させ,過剰発現はこれらのプロセスを強化した.
- piR- hsa-26925はMETTL3と相互作用し,m6Aメチル化レベルと下流標的EPHB2の発現に影響する.
- METTL3抑制またはEPHB2過剰発現は,細胞侵入に対するpiR- hsa-26925の影響を部分的に逆転させた.
結論:
- piR- hsa-26925は肺腺がんにおける腫瘍遺伝子として作用し,侵入と転移を促進する.
- piR- hsa-26925/ METTL3軸はEPHB2 m6Aメチル化を調節し,それによって肺腺がん細胞の悪性腫瘍を制御する.
- この経路は肺アデノカルシノーマ治療の潜在的治療目標です.
関連する概念動画
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
MicroRNAs
21.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.6K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K


